Pulse Biosciences Inc Logo

Pulse Biosciences Inc (6L8)

FSX

Currency in EUR
42.80
-1.00 (-2.28%)

Real-time Data

06:00 AM

Day's Range

42.80
43.80

52 wk Range

10.80
48.40

Overview - 6L8 - Pulse Biosciences Inc

Key Statistics

Valuation

Enterprise Value

2.63B

P/E (Trailing)

‪-39.25‬

P/E (Forward)

‪-26.54‬

PEG Ratio

‪-1.37‬

Price / Sales (TTM)

‪2,588.07‬

Price / Book

‪34.44‬

EV / EBITDA

‪-35.97‬

Profitability

Gross Margin

‪37.09%‬

Profit Margin

‪-54.00%‬

Operating Margin

‪-5,823.04%‬

Return on Assets

‪-44.33%‬

Return on Equity

‪-78.49%‬

Ownership

Shares Outstanding

70.79M

Float

20.64M

Held by Insiders

‪71.04%‬

Held by Institutions

‪15.40%‬

Price stats

Beta

‪1.62‬

50-Day Avg

‪40.65‬

200-Day Avg

‪24.05‬

News Teaser - 6L8 - Pulse Biosciences Inc

News & Analysis

View all news

Market Cap - 6L8 - Pulse Biosciences Inc

Peers - 6L8 - Pulse Biosciences Inc

Peer Comparison

Compared with companies in Medical Instruments & Supplies listed on FSX.

Profile Summary - 6L8 - Pulse Biosciences Inc

About

Pulse Biosciences Inc is a bioelectric medicine company focused on developing and commercializing medical technologies that use proprietary pulsed-field energy to treat targeted cells while preserving surrounding tissue. Its current product portfolio includes the nPulse System for benign skin lesions, the nPulse…

SectorHealthcare
IndustryMedical Instruments & Supplies
Employees116
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.